2m 2m 2m 2m 2m 2m 2m
ENVOY MED-A (COCH)
NASDAQ
$0.65-$0.002 (-0.31%)
Price as of Jun 23, 2026 4:10 PM EDT- $50.8MMarket Cap
- -54.23%1-Year Change
- Medical DevicesIndustry
ENVOY MED-A (COCH)
$0.65-$0.002 (-0.31%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 241,000 +7.11% | 225,000 -28.80% | 316,000 N/A | N/A N/A | |
Cost of Revenue | 874,000 +17.79% | 742,000 -5.96% | 789,000 -83.86% | 4.9M -6.09% | |
Gross Profit | -633,000 +22.44% | -517,000 +9.30% | -473,000 -90.32% | -4.9M -6.09% | |
Sales and Marketing Expense | 1.2M -29.64% | 1.7M +4.08% | 1.7M N/A | N/A N/A | |
Research and Development Expense | -12.5M +22.66% | -10.2M +13.66% | -9.0M N/A | N/A N/A | |
Depreciation and Amortization Expense | 302,000 +74.57% | 173,000 +30.08% | 133,000 N/A | N/A N/A | |
Total Operating Expenses | 22.5M +15.55% | 19.5M +4.25% | 18.7M +282.29% | 4.9M -6.09% | |
Operating Profit | -22.3M +15.65% | -19.3M +4.82% | -18.4M +275.83% | -4.9M -6.09% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | 6.1M +16,161.88% | |
Interest Expense | -1.6M +94.85% | -816,000 N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | -1.6M +94.85% | -816,000 N/A | 0 -100.00% | 6.1M +16,161.88% | |
Total Nonoperating Income and Expense | -1.5M -3.44% | -1.5M -86.66% | -11.5M N/A | N/A N/A | |
Income before Taxes | -28.7M +2.46% | -28.0M -6.47% | -29.9M -244.24% | 20.7M +498.38% | |
Income Taxes | N/A N/A | 2.6M -55.25% | 5.8M +284.63% | 1.5M N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -23.8M +14.24% | -20.8M -30.47% | -29.9M -255.50% | 19.2M +7,743.56% | |
Net Income from Continuing Operations Applicable to Common | -28.7M +2.46% | -28.0M -6.47% | -29.9M -244.24% | 20.7M +8,340.34% | |
Basic EPS and Net Income | -1.23 -17.45% | -1.49 -37.39% | -2.38 -430.56% | 0.72 +3,700.00% | |
Diluted EPS and Net Income | -1.23 -17.45% | -1.49 -37.39% | -2.38 -430.56% | 0.72 +3,700.00% | |
Basic Weighted Average Shares | 23.3M +23.78% | 18.8M +49.69% | 12.6M -76.37% | 53.1M +15.96% | |
Diluted Weighted Average Shares | 23.3M +23.78% | 18.8M +49.69% | 12.6M -76.37% | 53.1M +15.96% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 3.7M -31.81% | 5.5M +29.99% | 4.2M +3,813.78% | 107,773 -28.08% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 3.7M -31.81% | 5.5M +29.99% | 4.2M +3,813.78% | 107,773 -28.08% | |
Total Current Assets | 6.3M -33.09% | 9.4M +37.49% | 6.8M +2,996.33% | 220,422 -74.46% | |
Accumulated Depreciation | 5.1M +5.78% | 4.8M N/A | N/A N/A | N/A N/A | |
Property and Plant and Equipment and Net | 1.0M -18.82% | 1.3M +263.25% | 351,000 N/A | N/A N/A | |
Total Long-Term Assets | 1.0M -18.82% | 1.3M +263.25% | 351,000 -99.92% | 430.0M +1.16% | |
Total Assets | 8.6M -25.83% | 11.5M +51.02% | 7.6M -98.23% | 430.6M +0.87% | |
Income Taxes Payable | 2.2M N/A | N/A N/A | N/A N/A | 686,530 N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 11.6M +53.38% | 7.5M +13.59% | 6.6M -9.22% | 7.3M +172.94% | |
Total Long-Term Debt | 9.3M -50.13% | 18.7M -69.57% | 61.5M +8,275.32% | 734,300 -2.09% | |
Total Long-Term Liabilities | 27,000 -96.97% | 891,000 -21.84% | 1.1M +6.87% | 1.1M -94.94% | |
Total Liabilities | 20.3M -33.10% | 30.4M +223.12% | 9.4M -49.96% | 18.8M -51.35% | |
Retained Earnings | -313.4M +10.07% | -284.7M +10.69% | -257.2M +1,335.84% | -17.9M -51.20% | |
Total Stockholders Equity | -12.2M -35.47% | -18.8M +969.35% | -1.8M -90.16% | -17.9M -51.20% | |
Total Shares Outstanding | 28.9M +35.68% | 21.3M +9.09% | 19.5M +353.30% | 4.3M -40.00% | |
Cash Flow | |||||
Cash from Operating Activities | -18.2M +1.40% | -17.9M +1.67% | -17.7M +564.29% | -2.7M -18.00% | |
Capital Expenditures | 179,000 -81.73% | 980,000 +540.52% | 153,000 N/A | N/A N/A | |
Cash from Investing Activities | -179,000 -81.73% | -980,000 +540.52% | -153,000 -113.72% | 1.1M +100.26% | |
Dividends Paid | 1.8M -25.66% | 2.4M -54.69% | 5.4M N/A | N/A N/A | |
Cash from Financing Activities | 16.6M -17.65% | 20.2M -7.54% | 21.8M +1,356.33% | 1.5M -99.65% | |
Financials Ratio | |||||
Gross Margin | -262.66% +14.31% | -229.78% +53.51% | -149.68% N/A | N/A N/A | |
Operating Margin | -9,240.66% +7.97% | -8,558.22% +47.21% | -5,813.61% N/A | N/A N/A | |
Return on Assets | -236.43% +9.02% | -216.86% +1,488.92% | -13.65% -404.25% | 4.49% N/A | |
Return on Equity | 153.26% -24.07% | 201.85% -33.60% | 303.99% +531.71% | -70.42% N/A | |
Revenue Growth | 7.11% +124.69% | -28.80% N/A | N/A N/A | N/A N/A | |
Current Ratio | 0.54 -56.37% | 1.24 +21.04% | 1.03 +3,305.63% | 0.03 N/A | |
Cash Ratio | 0.32 -55.54% | 0.73 +14.44% | 0.64 +4,223.81% | 0.01 N/A | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow